Angelor
Finance · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
22 Rue Seguin, Lyon, Auvergne-Rhone-Alpe...Phone Number
+33 478594090Website
www.angelor.frRevenue
<$5 MillionIndustry
About Angelor
Is Angelor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Angelor had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Angelor has new funding data
Check out if Angelor is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Angelor
Product Launch: Get notified when Angelor launches new products
Check if Angelor has recently received funding, and reach out quickly before it becomes old news!
Angelor, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Angelor recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Angelor is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Angelor is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Angelor.
Angelor Tech Stack
A closer look at the technologies used by Angelor
Angelor News & Media
Axoltis Pharma raises €18 million to accelerate development of Amyotrophic Lateral ...
Clermont-Ferrand, France, December 2, 2025 – Axoltis Pharma, a biotech company dedicated to developing novel therapeutic solutions for neurodegenerative diseases, today announces the closing of a Series A funding round worth €18 million ($20.9M), to be disbursed in two installments. The funding, which includes new a...Brenus Pharma Raises $25 Million to Accelerate Clinical Trials of Its Precision Cancer Vaccines.
LYON, France--(BUSINESS WIRE)--Brenus Pharma, a biotech company specializing in the development of cancer vaccines, announces the completion of a $25 million Series A financing round. The round is led by Angelor, an investment fund bringing together a cluster of investors from the Auvergne-Rhône-Alpes (AURA) region, including UI Investissement for the Fonds régional Avenir industrie Auvergne-Rhône-Alpes, Crédit Agricole Centre-France and Crédit Agricole Centre-Est, with 2 family offices. BelgiaClub-Employés raises €1.5 million to expand its well-being at work concept to 5 cities in France
Lyon and Paris-based Club-Employés, a startup specialized in products and services for employees, announces that it has raised €1.5 million from Angelor and BPI. It will use the funds to strengthen its sales teams, develop its marketing approach and continue to develop new features. Club-Employé
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Angelor
Angelor is a network of experienced business leaders dedicated to financing and supporting innovative entrepreneurs for the common good. The company focuses on responsible investment in sectors that address societal challenges, such as health, nutrition, and the environment. Angelor aims to foster sustainable businesses by providing entrepreneurs w... Read More